title: NRAMP1 (SLC11A1) variants: genetic susceptibility to multiple Sclerosis.
abstract: OBJECTIVE
  Multiple sclerosis (MS) is an inflammatory, autoimmune demyelinating disease of the central nervous system. Human Natural Resistance Associated Macrophage Protein 1 (NRAMP1) gene polymorphisms have been implicated in the immune mediated diseases susceptibility. This study aimed to investigate the plausible association between NRAMP1 gene and MS susceptibility.
  
  
  METHODS
  We analyzed (GT)(n,) INT4, 3'UTR and D543N polymorphisms of NRAMP1 gene in 100 MS patients and 104 healthy subjects by using amplification refractory mutation system-polymerase chain reaction and sequence analysis.
  
  
  RESULTS
  No significant association was found between (GT)(n,) INT4, 3'UTR and D543N polymorphisms and MS. There was also no correlation between NRAMP1 polymorphisms and MS clinical forms.
  
  
  CONCLUSIONS
  Our findings suggest that NRAMP1 polymorphisms do not play a role in MS susceptibility and clinical finding of MS in Turkish patients.
authors.affiliation: Department of Medical Biology, Medical Faculty, Gaziosmanpasa University, 60100, Tokat, Turkey. omerates27@yahoo.com
authors.forename: Omer
authors.initials: O
authors.lastname: Ates
authors.forename: Semiha
authors.initials: S
authors.lastname: Kurt
authors.forename: Nihan
authors.initials: N
authors.lastname: Bozkurt
authors.forename: Hatice
authors.initials: H
authors.lastname: Karaer
mesh_terms: D016022:Case-Control Studies; D027682:Cation Transport Proteins / Q000235:genetics*; D004252:DNA Mutational Analysis / Q000379:methods; D020022:Genetic Predisposition to Disease; D006801:Humans; D009103:Multiple Sclerosis / Q000235:genetics*; D011110:Polymorphism, Genetic; D014421:Turkey; D000099173:Natural Resistance-associated Macrophage Protein 1
chemical_list: D027682:Cation Transport Proteins; D000099173:Natural Resistance-associated Macrophage Protein 1
references.citation: Surgery. 1997 Aug;122(2):173-8; discussion 178-9
references.pmid: 9288120
references.citation: Semin Neurol. 1998;18(3):295-9
references.pmid: 9817533
references.citation: Ann Neurol. 1993 Mar;33(3):281-5
references.pmid: 8498811
references.citation: EMBO J. 1999 Aug 16;18(16):4361-71
references.pmid: 10449402
references.citation: Infect Immun. 1999 Mar;67(3):1386-92
references.pmid: 10024586
references.citation: Mol Med. 1995 Jan;1(2):194-205
references.pmid: 8529098
references.citation: Int J Immunogenet. 2009 Feb;36(1):15-9
references.pmid: 19055603
references.citation: Neurol Sci. 2000;21(4 Suppl 2):S843-7
references.pmid: 11205360
references.citation: J Med Genet. 1996 Aug;33(8):672-7
references.pmid: 8863160
references.citation: J Med Genet. 1999 Apr;36(4):295-9
references.pmid: 10227396
references.citation: Tissue Antigens. 2002 Apr;59(4):311-5
references.pmid: 12135431
references.citation: Metab Brain Dis. 2006 Sep;21(2-3):163-9
references.pmid: 16865539
references.citation: J Clin Immunol. 2008 Jan;28(1):73-7
references.pmid: 17876529
references.citation: J Autoimmun. 2003 Sep;21(2):111-6
references.pmid: 12935779
references.citation: Ann Neurol. 2005 Dec;58(6):840-6
references.pmid: 16283615
references.citation: Metabolism. 2005 May;54(5):628-33
references.pmid: 15877293
references.citation: Curr Opin Neurol. 2009 Jun;22(3):219-25
references.pmid: 19387341
references.citation: Mult Scler. 2004 Dec;10(6):618-20
references.pmid: 15584484
references.citation: Blood Cells Mol Dis. 2004 Jul-Aug;33(1):45-50
references.pmid: 15223010
references.citation: Blood Cells Mol Dis. 2001 Jan-Feb;27(1):44-53
references.pmid: 11358358
references.citation: Rheumatol Int. 2009 May;29(7):787-91
references.pmid: 18998137
references.citation: Can J Neurol Sci. 2008 Sep;35(4):491-4
references.pmid: 18973068
references.citation: Immunol Lett. 1999 Jan;65(1-2):73-80
references.pmid: 10065630